Tissue Engineering: Focus on the Cardiovascular System - Biomaterials Science: An Integrated Clinical and Engineering Approach - page 181

3. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured
in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA.
Dec 1981; 78(12): 7634-7638.
4. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E,
Binah O, Itskovitz-Eldor J, Gepstein L. Human embryonic stem cells can differen-
tiate into myocytes with structural and functional properties of cardiomyocytes.
J Clin Invest. Aug 2001; 108(3): 407-414.
5. Xu C, Police S, Rao N, Carpenter MK. Characterization and enrichment of car-
diomyocytes derived from human embryonic stem cells. Circ Res. Sep 20 2002;
91(6): 501-508.
6. Mummery C, Ward-van Oostwaard D, Doevendans P, Spijker R, van den Brink
S, Hassink R, van der Heyden M, et al. Differentiation of human embryonic stem
cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells.
Circulation. Jun 3 2003; 107(21): 2733-2740.
7. Caspi O, Itzhaki I, Arbel G, Kehat I, Gepstien A, Huber I, Satin J, Gepstein L.
In vitro electrophysiological drug testing using human embryonic stem cell
derived cardiomyocytes. Stem Cells Dev. May 29 2008.
8. Kehat I, Gepstein A, Spira A, Itskovitz-Eldor J, Gepstein L. High-resolution elec-
trophysiological assessment of human embryonic stem cell-derived cardiomyo-
cytes: A novel in vitro model for the study of conduction. Circ Res. Oct 18 2002;
91(8): 659-661.
9. Snir M, Kehat I, Gepstein A, Coleman R, Itskovitz-Eldor J, Livne E, Gepstein L.
Assessment of the ultrastructural and proliferative properties of human embry-
onic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol. Dec 2003;
285(6): H2355-2363.
10. McDevitt TC, Laflamme MA, Murry CE. Proliferation of cardiomyocytes
derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/
Akt signaling pathway. J Mol Cell Cardiol. Dec 2005; 39(6): 865-873.
11. Caspi O, Lesman A, Basevitch Y, Gepstein A, Arbel G, Habib IH, Gepstein L,
Levenberg S. Tissue engineering of vascularized cardiac muscle from human
embryonic stem cells. Circ Res. Feb 2 2007; 100(2): 263-272.
12. Lesman A, Habib M, Caspi O, Gepstein A, Arbel G, Levenberg S, Gepstein L.
Transplantation of a tissue-engineered human vascularized cardiac muscle.
Tissue Eng Part A. Jan; 16(1): 115-125.
13. Caspi O, Huber I, Kehat I, Habib M, Arbel G, Gepstein A, Yankelson L, Aronson
D, Beyar R, Gepstein L. Transplantation of human embryonic stem cell-derived
cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am
Coll Cardiol. Nov 6 2007; 50(19): 1884-1893.
14. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK,
Reinecke H, et al. Cardiomyocytes derived from human embryonic stem cells
in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol.
Sep 2007; 25(9): 1015-1024.
15. Leor J, Gerecht S, Cohen S, Miller L, Holbova R, Ziskind A, Shachar M,
Feinberg MS, Guetta E, Itskovitz-Eldor J. Human embryonic stem cell trans-
plantation to repair the infarcted myocardium. Heart. Oct 2007; 93(10):
1278-1284.
16. Tomescot A, Leschik J, Bellamy V, Dubois G, Messas E, Bruneval P, Desnos
M et al. Differentiation in vivo of cardiac committed human embryonic stem
cells in postmyocardial infarcted rats. Stem Cells. Sep 2007; 25(9): 2200-2205.